Search research articles
Contact Us
Filters
Showing results (61-70 of 174) with videos related to
Page
of 18
Sort By:
Annals of the Rheumatic Diseases
|
May 13, 2016
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)
Vibeke Strand, Philip Mease, Laure Gossec, et al.
Eclinicalmedicine
|
April 8, 2024
Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system
Yeon Mi Hwang, Qi Wei, Samantha N Piekos, et al.
Pain
|
July 6, 2010
Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine
Lauren B Marangell, Daniel J Clauw, Ernest Choy, et al.
Patient Preference and Adherence
|
October 2, 2019
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population
Diana Brixner, Manish Mittal, David T Rubin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 23, 2023
Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system
Yeon Mi Hwang, Qi Wei, Samantha N Piekos, et al.
Rheumatology and Therapy
|
January 7, 2026
Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip Mease, Xiaolan Ye, Christopher D Saffore, et al.
The Journal of Rheumatology
|
August 2, 2021
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, et al.
The Journal of Rheumatology
|
November 16, 2020
Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
Tanja Schjødt Jørgensen, Marie Skougaard, Rebekka Lund Hansen, et al.
Clinical Therapeutics
|
March 17, 2012
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine
Robert Bennett, I Jon Russell, Ernest Choy, et al.
Clinical Rheumatology
|
July 12, 2022
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results
Laura C Coates, Philip Mease, Andris Kronbergs, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 174) with videos related to
Sort By:
Page
of 18
Annals of the Rheumatic Diseases
|
May 13, 2016
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)
Vibeke Strand, Philip Mease, Laure Gossec, et al.
Eclinicalmedicine
|
April 8, 2024
Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system
Yeon Mi Hwang, Qi Wei, Samantha N Piekos, et al.
Pain
|
July 6, 2010
Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine
Lauren B Marangell, Daniel J Clauw, Ernest Choy, et al.
Patient Preference and Adherence
|
October 2, 2019
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population
Diana Brixner, Manish Mittal, David T Rubin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 23, 2023
Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system
Yeon Mi Hwang, Qi Wei, Samantha N Piekos, et al.
Rheumatology and Therapy
|
January 7, 2026
Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip Mease, Xiaolan Ye, Christopher D Saffore, et al.
The Journal of Rheumatology
|
August 2, 2021
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, et al.
The Journal of Rheumatology
|
November 16, 2020
Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
Tanja Schjødt Jørgensen, Marie Skougaard, Rebekka Lund Hansen, et al.
Clinical Therapeutics
|
March 17, 2012
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine
Robert Bennett, I Jon Russell, Ernest Choy, et al.
Clinical Rheumatology
|
July 12, 2022
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results
Laura C Coates, Philip Mease, Andris Kronbergs, et al.
Page
of 18